Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 54: 207-208, 2008; 10.1373/clinchem.2007.098319
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wennberg, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wennberg, R.
Related Collections
Right arrow Citation Classics
(Clinical Chemistry. 2008;54:207-208.)
© 2008 American Association for Clinical Chemistry, Inc.

Citation Classics

Unbound Bilirubin: A Better Predictor of Kernicterus?

Richard Wennberg1,1

1 Division of Neonatology, Department of Pediatrics, University of Washington, Seattle, WA.

Address correspondence to the author at: Division of Neonatology, Department of Pediatrics, University of Washington, Box 356320, Seattle, WA 98195. e-mail rpwennberg@hotmail.com.

The first 20% of the full text of this article appears below.

The peroxidase method described in this paper measures non–protein-bound bilirubin by oxidation of the free fraction. The oxidation rate is slow compared with rapid dissociation of albumin-bound bilirubin. Thus, the unbound bilirubin can be estimated from the initial rate of decline in total bilirubin concentration.

In the 1970s, severe neonatal hyperbilirubinemia and kernicterus were major clinical problems. Kernicterus could usually be prevented by administering an exchange transfusion to infants whose serum unconjugated bilirubin concentration reached 341 µmol/L (20 mg/dL), but the diagnostic specificity of 341 µmol/L (20 mg/dL) was quite poor. Premature infants sometimes developed encephalopathy at very low bilirubin concentrations, especially when receiving sulfonamides.

While engaged in a fellowship in neonatal medicine, I was stimulated by Gerald Odell’s 1959 paper, in which he used pharmacological arguments to explain how these drugs produced kernicterus by competitively . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.